G. Eisenbarth

Genetics · 2001–2013

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom G. Eisenbarth trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Mark Atkinson

Who trusts G. Eisenbarth overall

  1. Mark Atkinson

Papers from G. Eisenbarth's perspective

Ordered by how strongly the researchers G. Eisenbarth trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. (The Lancet)
  2. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. (New England Journal of Medicine)
  3. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children (Journal of the American Medical Association (JAMA))
  4. Diabetes Therapeutics News (Diabetes Care)
  5. Innate immunity and intestinal microbiota in the development of Type 1 diabetes (Nature)
  6. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. (Immunity)
  7. A core gut microbiome in obese and lean twins (Nature)
  8. Type 1 diabetes: etiology, immunology, and therapeutic strategies. (Physiological Reviews)
  9. Analysis of islet inflammation in human type 1 diabetes (Clinical and Experimental Immunology)
  10. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. (International Journal of Systematic and Evolutionary Microbiology)

Their papers